R
Robert Carruthers
H-index:24
Citation Count:2,218
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada
利妥昔单抗与奥瑞利珠单抗在加拿大不列颠哥伦比亚省复发型多发性硬化症中对临床复发和放射学结局的疗效比较
Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab
奥瑞利珠单抗治疗复发缓解型多发性硬化与原发进展型多发性硬化2年内代谢物变化的纵向磁共振波谱研究
Increased PET 11C-PBR28 Binding in Multiple Sclerosis Normal-Appearing White Matter Correlates with MRI Measures of Myelin Loss
多发性硬化正常外观白质中PET 11C-PBR28结合的增加与髓鞘丢失的MRI测量值相关
Enhancing public health response: a framework for topics and sentiment analysis of COVID-19 in the UK using Twitter and the embedded topic model
增强公共卫生反应: 使用Twitter和嵌入式主题模型对英国新型冠状病毒肺炎进行主题和情感分析的框架
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
anti-CD20治疗对CD4和CD8 T细胞的差异作用以及CD20-expressing CD8 T细胞在MS疾病活动中的意义
Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study
在口服药物治疗多发性硬化症的人群中坚持实验室监测: 一项基于加拿大人群的研究

